Programme
Thursday, 29 Sept 2022
09:00-09:20
Opening of the Conference
09:20-09:50
Opening lecture: The Genetics of Aging: implications for pharmacological interventions and drug discovery
Michał Masternak (Burnett School of Biomedical Sciences Orlando FL, USA)
Michał Masternak (Burnett School of Biomedical Sciences Orlando FL, USA)
10:00-12:00
Session I - Pharmaceutical Innovations
Chair: Prof. Wanda Baer-Dubowska, Prof. Przemysław Mikołajczak
Chair: Prof. Wanda Baer-Dubowska, Prof. Przemysław Mikołajczak
10:00-10:30
Tracks and Traits in Pharmaceutical Biotechnology
Oliver Kayser (Technical University of Dortmund, Dept. Technical Biochemistry)
Oliver Kayser (Technical University of Dortmund, Dept. Technical Biochemistry)
10:30-11:00
Manufacturing concepts for personalised multi-drug combinations
Francisek Stepanek (University of Chemistry and Technology in Prague, Department of Chemical Engineering, Prague, Czech Republic)
Francisek Stepanek (University of Chemistry and Technology in Prague, Department of Chemical Engineering, Prague, Czech Republic)
11:00-11:30
Biofarm - Innovations - cooperation with science
Jarosław Pieczuro (Biofarm, Poznań)
Jarosław Pieczuro (Biofarm, Poznań)
11:30-12:00
Can a generic company be innovative?
Ewa Tratkiewicz (Polpharma, Warszawa)
Ewa Tratkiewicz (Polpharma, Warszawa)
09:00-17:00
Poster Session, hall
12:00-12:30
☕ Coffee break
12:30-13:45
Session II - Knowledge transfer
Chair: Prof. Lucjusz Zaprutko, Prof. Maria Rybczyńska, Jacek Wajda MSc
Chair: Prof. Lucjusz Zaprutko, Prof. Maria Rybczyńska, Jacek Wajda MSc
Special session - Pharmacy and business - Presentation of the possibilities of the Center of Innovative Pharmaceutical Technology
12:30-12:45
Science-Industry. How far are we, how close?
Janina Lulek (Uniwersytet Medyczny w Poznaniu, Katedra i Zakład Technologii Postaci Leku, Poznań)
Janina Lulek (Uniwersytet Medyczny w Poznaniu, Katedra i Zakład Technologii Postaci Leku, Poznań)
12:45-13:00
From basic research to ...?
Judyta Cielecka-Piontek (Uniwersytet Medyczny w Poznaniu, Katedra i Zakład Farmakognozji, Poznań)
Judyta Cielecka-Piontek (Uniwersytet Medyczny w Poznaniu, Katedra i Zakład Farmakognozji, Poznań)
13:00-13:15
Cosmetics industry - innovation as an opportunity for the industry
Justyna Koziej (Instytut Badań Kosmetyków, Warszawa)
Justyna Koziej (Instytut Badań Kosmetyków, Warszawa)
13:15-13:30
Cooperation with science - own experience
Grzegorz Garbacz (Physiolution, Greiswald, Niemcy)
Grzegorz Garbacz (Physiolution, Greiswald, Niemcy)
13:30-13:45
Transfer of knowledge on the line of enterprise - unit, science - current state - challenges
Arkadiusz Hejduk (LEK-AM, Zakroczym)
Arkadiusz Hejduk (LEK-AM, Zakroczym)
13:45-15:00
🍽 Lunch break
15:00-17:00
Sesssion III - Interdisciplinarity in modern pharmacy
Chair: Prof. Marzena Gajęcka, Prof. Tomasz Gośliński
Chair: Prof. Marzena Gajęcka, Prof. Tomasz Gośliński
15:00-15:30
Structural biology of G protein-coupled receptors reveals novel opportunities in precise design of signal biased agonists
Krzysztof Jóźwiak (Medical University of Lublin, Department of Biopharmacy, Lublin, Poland)
Krzysztof Jóźwiak (Medical University of Lublin, Department of Biopharmacy, Lublin, Poland)
15:30-16:00
Thiazolidinone structure as a promising scaffold in medicines of the future
Roman Lesyk (Danylo Halytsky Lviv National Medical University, Lviv, Ukraine)
Roman Lesyk (Danylo Halytsky Lviv National Medical University, Lviv, Ukraine)
16:00-16:30
Signal transduction in Development of Cancer
Walter Birchmeier (Max Delbruck Center for Molecular Medicine/Charite Humbold University, Berlin Germany)
Walter Birchmeier (Max Delbruck Center for Molecular Medicine/Charite Humbold University, Berlin Germany)
16:30-17:00
Phthalocyanines and their analogues in photodynamic therapy
Petr Zimčík (Charles University in Prague Department of Pharmaceutical Chemistry and Drug Control, in Hradec Kralove)
Petr Zimčík (Charles University in Prague Department of Pharmaceutical Chemistry and Drug Control, in Hradec Kralove)
19:00
Opening ceremony with the opening of Collegium Pharmaceuticum
Friday, 30 Sept 2022
09:00-09:30
Plenary lecture - Conditions for good cooperation between the university and the pharmaceutical industry
Małgorzata Sznitowska (Gdański Uniwersytet Medyczny)
Małgorzata Sznitowska (Gdański Uniwersytet Medyczny)
09:30-11:00
Session IV - Searching for the new pharmaceutical strategies
Chair: Prof. Marek Murias, Assoc. prof. Violetta Krajka-Kuźniak
Chair: Prof. Marek Murias, Assoc. prof. Violetta Krajka-Kuźniak
Satellite session - Building effective addiction prevention (hall C)
Chair: Prof. Ewa Florek, Deputy Director of the Department of Health and Social Affairs of the Poznań City Hall Ms Joanna Olenderek
Chair: Prof. Ewa Florek, Deputy Director of the Department of Health and Social Affairs of the Poznań City Hall Ms Joanna Olenderek
09:30-10:00
New preclinical model of triple negative breast cancer: powerful tool for studying tumor biology and development of new strategies and targets for therapys
Kamil Lisek (Max Delbruck Center for Molecular Medicine/Charite Humbold University, Berlin Germany)
Kamil Lisek (Max Delbruck Center for Molecular Medicine/Charite Humbold University, Berlin Germany)
09:30-10:00
Discussion panel: Cooperation of the Poznań City Hall with the Poznan University of Medical Sciences in the field of addiction prevention
Moderators: Prof. Ewa Florek (PUMS, Poland), Deputy Director of the Department of Health and Social Affairs of the Poznań City Hall Ms Joanna Olenderek, Prof. Ewa Baum (PUMS, Poland), dr Artur Teżyk (PUMS, Poland), dr Eryk Matuszkiewicz (Hospital of F. Raszeja, Poland), Commander Szymon Witczak from the Prevention Department of the Provincial Police Headquarters in Poznań, Poland
Moderators: Prof. Ewa Florek (PUMS, Poland), Deputy Director of the Department of Health and Social Affairs of the Poznań City Hall Ms Joanna Olenderek, Prof. Ewa Baum (PUMS, Poland), dr Artur Teżyk (PUMS, Poland), dr Eryk Matuszkiewicz (Hospital of F. Raszeja, Poland), Commander Szymon Witczak from the Prevention Department of the Provincial Police Headquarters in Poznań, Poland
10:00-10:30
RNA interference in cancer therapy
Błażej Rubiś (Poznań University of Medical Sciences, Department of Clinical Chemistry and Molecular Diagnostics)
Błażej Rubiś (Poznań University of Medical Sciences, Department of Clinical Chemistry and Molecular Diagnostics)
10:00-10:30
Epidemiology of addictions among adolescents - Poznań, Poland, Europe. Effective prevention strategies and programs
Ewa Florek (PUMS Poland)
Ewa Florek (PUMS Poland)
10:30-10:45
Support for clinical trials in ABM projects
Zbigniew Petrycki i Krzysztof Gąsiorowski (Neuca)
Zbigniew Petrycki i Krzysztof Gąsiorowski (Neuca)
10:30-11:00
Spiritual development as a counterweight to addiction
Ewa Baum (PUMS Poland)
Ewa Baum (PUMS Poland)
10:45-11:00
Increased Confidence and Throughput in Pharmaceutical Analyses with Trapped Ion Mobility Mass Spectrometry
dr Christian Albers (Bruker Daltonics)
dr Christian Albers (Bruker Daltonics)
09:35-11:15
The Convention of Deans of Pharmaceutical Faculties of universities in Poland (Senate Hall) - SPECIAL EVENT!!!
11:00-11:30
☕ Coffee break
11:30-12:30
Session V - Teaching - educating pharmacists in relation to contemporary challenges
Chair/moderator: Prof. Edmund Grześkowiak, Prof. Anna Jelińska
Chair/moderator: Prof. Edmund Grześkowiak, Prof. Anna Jelińska
Round Table Discussion - Pharmacist - a profession with a future
(Deans of Pharmaceutical Faculties, representatives of students, representatives of entrepreneurs)
Moderators: Prof. Anna Jelińska (PUMS, Poland), Prof. Wojciech Miltyk (UM Białystok, Poland)
(Deans of Pharmaceutical Faculties, representatives of students, representatives of entrepreneurs)
Moderators: Prof. Anna Jelińska (PUMS, Poland), Prof. Wojciech Miltyk (UM Białystok, Poland)
Presentations (5 min., in polish or englis) of young scientists, doctoral students and students - authors distinguished by the Jury of scientific papers
11:30-11:35
The effect of the new hybrids of cannabidiol with selected NSAIDs on the NF-κB and STAT transcription factors in glioblastoma cells
Anna Rybarczyk, Aleksandra Majchrzak-Celińska, Anna Pawełczyk, Lucjusz Zaprutko, Violetta Krajka-Kuźniak
Anna Rybarczyk, Aleksandra Majchrzak-Celińska, Anna Pawełczyk, Lucjusz Zaprutko, Violetta Krajka-Kuźniak
11:35-11:40
New 2-(cyclohexylamino)thiazol-4(5H)-one derivatives as inhibitors of 11βhydroxyteroid dehydrogenase type 1
Szymon Baumgart, Renata Studzińska, Daria Kupczyk
Szymon Baumgart, Renata Studzińska, Daria Kupczyk
11:40-11:45
The effect of hypoxia on p53 protein expression in breast cancer cells (MCF7) and cells transfected with prolidase vector (MCF7PL)
Magda Chalecka, Natalia Kowalczuk, Arkadiusz Surażyński
Magda Chalecka, Natalia Kowalczuk, Arkadiusz Surażyński
11:45-11:50
Analysis of homogeneity of unexpired and expired tablets containing nifuroxazide using a hyperspectral camera
Michał Meisner, Beata Szulc-Musioł, Beata Sarecka-Hujar
Michał Meisner, Beata Szulc-Musioł, Beata Sarecka-Hujar
11:50-11:55
Study of the composition of selected bee products
Eliza Matuszewska, Jan Matysiak
Eliza Matuszewska, Jan Matysiak
11:55-12:00
Development and mechanical properties of agomelatine-loaded hydrogels for depression
Monika Wojtyłko, Dimitrios A. Lamprou, Anna Froelich, Barbara Jadach, Ariadna Nowicka, Radosław Wichniarek, Wiesław Kuczko, Mirosław Szybowicz, Antoni Białek, Tomasz Osmałek
Monika Wojtyłko, Dimitrios A. Lamprou, Anna Froelich, Barbara Jadach, Ariadna Nowicka, Radosław Wichniarek, Wiesław Kuczko, Mirosław Szybowicz, Antoni Białek, Tomasz Osmałek
12:00-12:05
Hepatotoxicity in vivo of polydopamine with chemo-photothermal therapy
Marta Witkowska, Ewa Florek, Radosław Mrówczyński, Bartosz Grześkowiak, Izabela Miechowicz
Marta Witkowska, Ewa Florek, Radosław Mrówczyński, Bartosz Grześkowiak, Izabela Miechowicz
12:05-12:10
Simultaneous intravenous administration of fluconazole with analgesics – in vitro tudies
Katarzyna Dominiak, Gabriela Anglart, Katarzyna Dettlaff
Katarzyna Dominiak, Gabriela Anglart, Katarzyna Dettlaff
12:10-12:15
Nanoformulations of natural phytochemicals in glioblastoma treatment
Ludwika Piwowarczyk, Violetta Krajka-Kuźniak, Dariusz T. Młynarczyk, Aleksandra Majchrzak-Celińska, Anna Budzianowska, Szymon Tomczak, Jaromir Budzianowski, Tomasz Gośliński, Anna Jelińska
Ludwika Piwowarczyk, Violetta Krajka-Kuźniak, Dariusz T. Młynarczyk, Aleksandra Majchrzak-Celińska, Anna Budzianowska, Szymon Tomczak, Jaromir Budzianowski, Tomasz Gośliński, Anna Jelińska
12:15-12:30
Dyskusja
12:30-13:50
Session VII - The role of pharmacy in clinical trials
Chair: Prof. Ewa Florek, Assoc. prof. Krzysztof Kus
Session under the patronage of the Medical Research Agency - SPECIAL EVENT!!!
Chair: Prof. Ewa Florek, Assoc. prof. Krzysztof Kus
Session under the patronage of the Medical Research Agency - SPECIAL EVENT!!!
12:30-12:50
Towards cooperation - the role of the Medical Research Agency in the development of the drug research market, biotechnological research and medical devices
Karolina Maria Nowak (Agencja Badań Medycznych - Medical Research Agency, Poland)
Karolina Maria Nowak (Agencja Badań Medycznych - Medical Research Agency, Poland)
12:50-13:10
Clinical trials market: World - Europe - Poland
Rafał Staszewski (PUMS, Poland)
Rafał Staszewski (PUMS, Poland)
13:10-13:30
The role of the pharmacist in clinical trials
Ewelina Korczowska (PUMS, Poland)
Ewelina Korczowska (PUMS, Poland)
13:30-13:50
The use of the mouse model in research on the development, progression and therapy of ovarian cancer
Krzysztof Książek (PUMS, Poland)
Krzysztof Książek (PUMS, Poland)
13:50-14:20
Summary of the Conference, award ceremony.
Conference Closing. Lunch
Conference Closing. Lunch
* lecturer in the process of confirmation
The organizers reserve the right to change the program.
updeated: 2022-10-27